Company: AMTX
Filing Date: 2025-02-04
Form Type: S-3/A
Source: 0001437749-25-002740
Chunk: 38

Company: AEMETIS, INC
Filing Date: 2025-02-04
Form: S-3/A
Chunk 38
---
 explain the particular terms of those securities and the extent to which these general provisions may apply. The specific terms of the units as described in a prospectus supplement or information incorporated by reference will supplement and, if applicable, may modify or replace the general terms described in this section.

This summary and any description of units in the applicable prospectus supplement, information incorporated by reference or related free writing prospectus is subject to and is qualified in its entirety by reference to the unit agreement, collateral arrangements and depositary arrangements, if applicable. We will file these documents with the SEC for incorporation by reference into this prospectus, as applicable. See “Available Information” and “Incorporation of Certain Information by Reference” for information on how to obtain a copy of a document when it is filed.

The applicable prospectus supplement, information incorporated by reference or related free writing prospectus may describe:

| ● | the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately; |

| ● | any provisions for the issuance, payment, settlement, transfer, or exchange of the units or of the securities composing the units; |

| ● | whether the units will be issued in fully registered or global form; and |

| ● | any other terms of the units. |

The applicable provisions described in this section, as well as those described under “Description of Debt Securities,” “Description of Capital Stock” and “Description of Warrants,” will apply to each unit and to each security included in each unit, respectively.

<div align='center'>USE OF PROCEEDS</div>

Unless otherwise indicated in the applicable prospectus supplement, information incorporated by reference or related free writing prospectus, we intend to use the net proceeds from the sale of securities for general corporate purposes.

<div align='center'>17

PLAN OF DISTRIBUTION</div>

We may sell the securities through underwriters or dealers, through agents, directly to one or more purchasers, through a rights offering, or otherwise. We will describe the terms of the offering of the securities in a prospectus supplement, information incorporated by reference or related free writing prospectus, including:

| ● | the name or names of any underwriters, if any; |

| ● | the purchase price of the securities and the proceeds we will receive from the sale; |

| ● | any underwriting discounts and other items constituting underwriters’ compensation; |

| ● | any initial public offering price; |

| ● | any discounts or